Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

DBV Submits VIASKIN Peanut Patch for FDA Approval Following Phase 3 Success

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

Another Potential Food Allergy Treatment is Snapped Up by Big Pharma

FDA Panel Deems Moderna COVID-19 Vaccine ‘Highly Effective’, No Serious Allergic...

Peanut Allergy Vaccine Takes Step Closer With Grant from Government of...

Viaskin Peanut “Patch” Therapy Takes Next Step Toward Approval… in Europe

Emergency Epinephrine Film Begins Phase 1 Clinical Trials

Aquestive’s Sublingual Epinephrine Film Receives FDA Fast Track Designation for Treatment...

Company Developing Therapy to Prevent “Allergic Cascade” Emerges from Stealth Mode

FDA Denies Approval of Viaskin Peanut “Patch” Therapy

Therapy Helps Children with Food Allergies Manage Severe Anxiety

Results of Aimmune’s Pivotal Phase 3 European Trial of PALFORZIA® Published...

Wheat OIT Shows Potential for Children in Small Study

Follow Us

Your School On Our Map

Put Your School on the Map